LPTX
Price
$0.36
Change
+$0.02 (+5.88%)
Updated
May 8 closing price
Capitalization
14.16M
SABS
Price
$1.72
Change
+$0.03 (+1.78%)
Updated
May 8 closing price
Capitalization
15.98M
Ad is loading...

LPTX vs SABS

Header iconLPTX vs SABS Comparison
Open Charts LPTX vs SABSBanner chart's image
Leap Therapeutics
Price$0.36
Change+$0.02 (+5.88%)
Volume$214.65K
Capitalization14.16M
SAB Biotherapeutics
Price$1.72
Change+$0.03 (+1.78%)
Volume$6.64K
Capitalization15.98M
LPTX vs SABS Comparison Chart
Loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPTX vs. SABS commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPTX is a Hold and SABS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (LPTX: $0.36 vs. SABS: $1.72)
Brand notoriety: LPTX and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPTX: 8% vs. SABS: 18%
Market capitalization -- LPTX: $14.16M vs. SABS: $15.98M
LPTX [@Biotechnology] is valued at $14.16M. SABS’s [@Biotechnology] market capitalization is $15.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPTX’s FA Score shows that 0 FA rating(s) are green whileSABS’s FA Score has 0 green FA rating(s).

  • LPTX’s FA Score: 0 green, 5 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, both LPTX and SABS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPTX’s TA Score shows that 6 TA indicator(s) are bullish while SABS’s TA Score has 6 bullish TA indicator(s).

  • LPTX’s TA Score: 6 bullish, 3 bearish.
  • SABS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LPTX is a better buy in the short-term than SABS.

Price Growth

LPTX (@Biotechnology) experienced а -13.03% price change this week, while SABS (@Biotechnology) price change was +1.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.07%. For the same industry, the average monthly price growth was +11.10%, and the average quarterly price growth was -13.37%.

Reported Earning Dates

LPTX is expected to report earnings on Mar 26, 2025.

SABS is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (-5.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SABS($16M) has a higher market cap than LPTX($14.2M). SABS YTD gains are higher at: -54.668 vs. LPTX (-87.440). SABS has higher annual earnings (EBITDA): -40.29M vs. LPTX (-64.24M). LPTX has more cash in the bank: 62.8M vs. SABS (30.4M). LPTX has less debt than SABS: LPTX (376K) vs SABS (4.52M). LPTX (0) and SABS (0) have equivalent revenues.
LPTXSABSLPTX / SABS
Capitalization14.2M16M89%
EBITDA-64.24M-40.29M159%
Gain YTD-87.440-54.668160%
P/E RatioN/AN/A-
Revenue00-
Total Cash62.8M30.4M207%
Total Debt376K4.52M8%
FUNDAMENTALS RATINGS
LPTX: Fundamental Ratings
LPTX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPTXSABS
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 18 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Ad is loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCDA2.850.20
+7.55%
BioCardia Inc.
GFS35.940.65
+1.84%
GlobalFoundries
WD71.580.19
+0.27%
Walker & Dunlop
UTL57.48-0.25
-0.43%
Unitil Corp
KLTR2.18-0.02
-0.91%
Kaltura

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with LPTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then LPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
+1.77%
LPTX - SABS
47%
Loosely correlated
+5.71%
MGX - SABS
32%
Poorly correlated
+9.66%
SLS - SABS
30%
Poorly correlated
-1.75%
HOOK - SABS
30%
Poorly correlated
-8.70%
INKT - SABS
29%
Poorly correlated
-6.22%
More